Discordance in Frailty Measures in Old Community Dwelling People with Multimorbidity – A Cross-Sectional Study by Lindh Mazya A, Axmon A, Sandberg M, Boström AM, W Ekdahl A

Get full text

The multiple sclerosis PRISMS study: Prevention of relapses and disability by interferon beta-1a subcutaneously in multiple sclerosis by Ebers, G, Oger, J, Paty, D, Li, D, Freedman, M, Hartung, H, Hommes, O, McLeod, J, Sandberg, M, Wikstrom, J, Carton, H, Hughes, R, Pancelius, M, Medaer, R, Blumhardt, L, Barnes, D, Bertelsmann, F, Chofflon, M, Kappos, L, King, J, Newsom-Davis, J, Sindic, C, Uitehaag, B, Van Doom, P, Bates, D

Randomized controlled trial of interferon-beta-1a in secondary progressive MS - Clinical results by King, J, McLeod, J, Gonsette, R, Duquette, P, Ebers, G, Rice, G, Francis, G, Lapierre, Y, Freedman, MS, Oger, J, Paty, D, Sorensen, P, Pelletier, J, Hommes, O, Jongen, P, Sanders, E, Andersen, O, Wollheim-Sandberg, M, Chofflon, M, Bates, D, Barnes, D, Blumhardt, L, Hawkins, C, Hughes, R, Palace, J